These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 698718)

  • 1. Labetalol in hypertensive emergencies.
    Br Med J; 1978 Sep; 2(6139):772. PubMed ID: 698718
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the alpha- and beta-adrenergic blocker labetalol in hypertensive crises].
    Kharchenko VI; Savenkov PM; Romanova LV; Arkhipov SN; Borisova GG
    Sov Med; 1983; (9):84-8. PubMed ID: 6648691
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
    Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
    Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Labetalol in the treatment of patients with hypertension and renal function impairment.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):135S-140S. PubMed ID: 526393
    [No Abstract]   [Full Text] [Related]  

  • 6. Labetalol in hypertensive emergencies.
    Wing LM
    Med J Aust; 1978 Jun; 1(12):658. PubMed ID: 683092
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of hypertensive emergencies with oral labetalol.
    Good CS
    Br Med J; 1978 Aug; 2(6135):501-2. PubMed ID: 678942
    [No Abstract]   [Full Text] [Related]  

  • 8. Labetalol in hypertensive emergencies.
    MacCarthy EP; Frost GW; Stokes GS
    Med J Aust; 1978 Apr; 1(7):399-400. PubMed ID: 672732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diazoxide vs. labetalol: a cross-over comparison of acute effects in hypertensive patients (author's transl)].
    Rumboldt Z; Bagatin J; Vidović A
    Lijec Vjesn; 1980 Nov; 102(11):619-23. PubMed ID: 7024692
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA; Brown JJ; Lever AF; Robertson AS; Robertson JI; Trust PM
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects].
    Raffo M; Cherchi A; Sau F; Pirisi R; Seguro C; Pisano MR
    Boll Soc Ital Cardiol; 1979; 24(6):657-66. PubMed ID: 551798
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperadrenergic syndrome in severe tetanus: extreme rise in catecholamines responsive to labetalol.
    Domenighetti GM; Savary G; Stricker H
    Br Med J (Clin Res Ed); 1984 May; 288(6429):1483-4. PubMed ID: 6426611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 15. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I; Luetić V
    Lijec Vjesn; 1983; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract]   [Full Text] [Related]  

  • 16. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O; Hirano J; Hirano K; Kubota Y; Numasawa K; Kawamura S
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M; Ansuini R; Pupita G; Campolucci G; Pupita F
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 20. [Labetolol in the therapy of secondary arterial hypertension. A polycentric study].
    Palla R; Giusti R; Marchitiello M; Menicucci R
    Minerva Nefrol; 1982; 29(2):105-10. PubMed ID: 7133539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.